We are live on ! Find out more
ENZN

ENZON PHARMACEUTICALS INC
ENZN

Delisted

ENZN was delisted on the 19th of May, 2016.

Back to rankings

40 hedge funds and large institutions have $8.07M invested in ENZON PHARMACEUTICALS INC in 2016 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% less funds holding

Funds holding: 49 → 40 (-9)

20% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 10

37% less capital invested

Capital invested by funds: $12.7M → $8.07M (-$4.64M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 9

Holders
40
Holders Change
-9
Holders Change %
-18.37%
% of All Funds
1.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
8
Reduced
10
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$24.5K
2
UBS Group
UBS Group
Switzerland
+$14.2K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$12.6K
4
OSAM
O'Shaughnessy Asset Management
Connecticut
+$4.65K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$2.13K

Top Sellers

Rank Fund Capital Flow
1
SCP
Seizert Capital Partners
Michigan
-$283K
2
Renaissance Technologies
Renaissance Technologies
New York
-$175K
3
KBC Group
KBC Group
Belgium
-$117K
4
AG
Algert Global
California
-$85K
5
Morgan Stanley
Morgan Stanley
New York
-$39.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
BJ
26
BlackRock Japan
Japan
$4K -$163 -334 -3%
Federated Hermes
27
Federated Hermes
Pennsylvania
$4K – – –
Morgan Stanley
28
Morgan Stanley
New York
$2K -$39.7K -81,356 -95%
AIG
29
American International Group
New York
$2K – – –
Manulife (Manufacturers Life Insurance)
30
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1K – – –
CFA
31
CT Financial Advisors
Pennsylvania
$940 – – –
Geode Capital Management
32
Geode Capital Management
Massachusetts
$93 – – –
SCP
33
Seizert Capital Partners
Michigan
– -$283K -414,810 Closed
KBC Group
34
KBC Group
Belgium
– -$117K -170,928 Closed
AG
35
Algert Global
California
– -$85K -124,891 Closed
CS
36
Credit Suisse
Switzerland
– -$17K -25,604 Closed
AFM
37
Anson Funds Management
Texas
– -$17K -25,000 Closed
TRCT
38
Tower Research Capital (TRC)
New York
– -$1K -2,177 Closed
Group One Trading
39
Group One Trading
Illinois
– -$1K -798 Closed
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
– +$146 +300 +3,000%
1
2

ENZN Hedge Fund Activity: Q1 2016 in Review

40 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in ENZON PHARMACEUTICALS INC (ENZN) for Q1 2016, worth a combined $8.07M — down 37% from $12.7M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of ENZN and 0 opened new positions — a net loss of 9 holders — while 10 trimmed existing stakes and 8 added.

The largest buyer was Jacobs Levy Equity Management, adding an estimated $24.5K. The largest seller was Seizert Capital Partners, exiting entirely with an estimated $283K sold.

  • 40 institutional investors held ENZON PHARMACEUTICALS INC (ENZN) as of Q1 2016, down from 49 in Q4 2015.
  • Funds reported $8.07M of ENZON PHARMACEUTICALS INC stock for Q1 2016, down 37% quarter-over-quarter.
  • 0 funds opened new ENZON PHARMACEUTICALS INC positions in Q1 2016 and 9 closed out, a net change of -9 holders.
  • The largest ENZON PHARMACEUTICALS INC buyer in Q1 2016 was Jacobs Levy Equity Management, an estimated $24.5K added.
  • The largest ENZON PHARMACEUTICALS INC seller in Q1 2016 was Seizert Capital Partners, an estimated $283K sold.

Based on aggregated 13F filings for Q1 2016.